Login / Signup

Subcutaneous Methylnaltrexone as Treatment for Opioid-Induced Constipation in Patients with Advanced Cancer and Noncancer Illnesses: A Post Hoc Analysis of Two Clinical Trials.

Eric D ShahBruce H ChamberlainMichelle RhinerNeal E SlatkinNancy StamblerRobert J Israel
Published in: Journal of pain research (2023)
SC methylnaltrexone was efficacious in inducing rapid RFL and safe among patients with and without active cancer suffering from OIC.
Keyphrases
  • advanced cancer
  • palliative care
  • clinical trial
  • papillary thyroid
  • chronic pain
  • pain management
  • randomized controlled trial
  • squamous cell carcinoma
  • drug induced
  • oxidative stress
  • lymph node metastasis